Siffert W - Search Results

1

Enhanced G protein activation in IDDM patients with diabetic nephropathy.

Pietruck F, Spleiter S, Daul A, Philipp T, Derwahl M, Schatz H, Siffert W. Pietruck F, et al. Among authors: siffert w. Diabetologia. 1998 Jan;41(1):94-100. doi: 10.1007/s001250050872. Diabetologia. 1998. PMID: 9498636

2

Signalling properties of lysophosphatidic acid in primary human skin fibroblasts: role of pertussis toxin-sensitive GTP-binding proteins.

Pietruck F, Busch S, Virchow S, Brockmeyer N, Siffert W. Pietruck F, et al. Among authors: siffert w. Naunyn Schmiedebergs Arch Pharmacol. 1997 Jan;355(1):1-7. doi: 10.1007/pl00004906. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9007835

3

Selectively enhanced cellular signaling by Gi proteins in essential hypertension. G alpha i2, G alpha i3, G beta 1, and G beta 2 are not mutated.

Pietruck F, Moritz A, Montemurro M, Sell A, Busch S, Rosskopf D, Virchow S, Esche H, Brockmeyer N, Jakobs KH, Siffert W. Pietruck F, et al. Among authors: siffert w. Circ Res. 1996 Nov;79(5):974-83. doi: 10.1161/01.res.79.5.974. Circ Res. 1996. PMID: 8888689

4

Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit.

Schäfers RF, Nürnberger J, Rütz A, Siffert W, Wenzel RR, Mitchell A, Philipp T, Michel MC. Schäfers RF, et al. Among authors: siffert w. Pharmacogenetics. 2001 Aug;11(6):461-70. doi: 10.1097/00008571-200108000-00001. Pharmacogenetics. 2001. PMID: 11505216

5

Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects.

Nürnberger J, Dammer S, Mitchell A, Siffert W, Wenzel RR, Gössl M, Philipp T, Michel MC, Schäfers RF. Nürnberger J, et al. Among authors: siffert w. Clin Pharmacol Ther. 2003 Jul;74(1):53-60. doi: 10.1016/S0009-9236(03)00087-0. Clin Pharmacol Ther. 2003. PMID: 12844135

6

Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3).

Mitchell A, Bührmann S, Seifert A, Nürnberger J, Wenzel RR, Siffert W, Philipp T, Schäfers RF. Mitchell A, et al. Among authors: siffert w. Clin Pharmacol Ther. 2003 Nov;74(5):499-504. doi: 10.1016/S0009-9236(03)00230-3. Clin Pharmacol Ther. 2003. PMID: 14586390 Clinical Trial.

7

Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH. Siffert W, et al. J Clin Invest. 1995 Aug;96(2):759-66. doi: 10.1172/JCI118120. J Clin Invest. 1995. PMID: 7635969 Free PMC article.

Epstein-Barr virus-immortalized B lymphoblasts obtained from hypertensive patients with enhanced Na+/H+ exchanger activity (HT cells) proliferate distinctly faster upon serum stimulation than those from normotensive controls with low exchanger activity (NT cells) (Rosskopf, D., E …

Epstein-Barr virus-immortalized B lymphoblasts obtained from hypertensive patients with enhanced Na+/H+ exchanger activity (HT cells) prolif …

8

Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.

Wenzel RR, Siffert W, Bruck H, Philipp T, Schäfers RF. Wenzel RR, et al. Among authors: siffert w. Pharmacogenetics. 2002 Aug;12(6):489-95. doi: 10.1097/00008571-200208000-00010. Pharmacogenetics. 2002. PMID: 12172218

9

The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.

Mitchell A, Rushentsova U, Siffert W, Philipp T, Wenzel RR. Mitchell A, et al. Among authors: siffert w. Clin Pharmacol Ther. 2006 Mar;79(3):274-81. doi: 10.1016/j.clpt.2005.11.008. Epub 2006 Feb 3. Clin Pharmacol Ther. 2006. PMID: 16513451 Clinical Trial.

10

Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism.

Mitchell A, Lückebergfeld B, Bührmann S, Rushentsova U, Nürnberger J, Siffert W, Schäfers RF, Philipp T, Wenzel RR. Mitchell A, et al. Among authors: siffert w. Clin Pharmacol Ther. 2004 Nov;76(5):396-408. doi: 10.1016/j.clpt.2004.07.011. Clin Pharmacol Ther. 2004. PMID: 15536455 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters